News & Events

Latest News

Charnwood Molecular receives its Crédit d'Impôt sur la Recherche (CIR) accreditation renewal for 2011, 2012 and 2013

Charnwood Molecular are pleased to announce that it has received its renewal approval of its accreditation to the Crédit d'Impôt sur la Recherche from the French Ministry of Higher Education and Research. The accreditation will be valid for the years 2011, 2012 and 2013.

Charnwood Molecular was first approved in 2009 and has since enjoyed successful collaborations with French pharmaceutical and biotech companies.

For further information please contact Dr Sylvain Blanc:

s.blanc@charnwood-molecular.com

Charnwood Molecular and Hybrigenics enter into collaboration through EUREKA Eurostars Programme.

Charnwood Molecular is pleased to announce that their EUREKA Eurostars Programme application in collaboration with French biotech Hybrigenics has been granted. The project titled “Industrialisation of Chemical Yeast 3-hybrid technology: applications to drug discovery and development and toxicoproteomics” has already started.

It will be dealing with the development of a new service based on yeast 3-hybrid technology for the detection of protein-ligand interactions in-vivo. The development of such product combining chemistry and genetics, will address several very important aspects of drug discovery and development.

For further information please contact Dr Sylvain Blanc:

s.blanc@charnwood-molecular.com